{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 21395, "end": 21620, "evidence": "ADA (2023) recommends a two-hour 75 OGTT at 4-12 weeks after delivery to check whether diabetes has remitted or the mother acquires T2DM, and once-a-year screening for diabetes, as 30-50% develop into T2DM in 10 years [9,37].", "text": "GDM screening window: 4-12 weeks", "score": 28, "kind": "atom", "claim_id": "c0001"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 21395, "end": 21620, "evidence": "ADA (2023) recommends a two-hour 75 OGTT at 4-12 weeks after delivery to check whether diabetes has remitted or the mother acquires T2DM, and once-a-year screening for diabetes, as 30-50% develop into T2DM in 10 years [9,37].", "text": "rate range: 30-50%", "score": 28, "kind": "atom", "claim_id": "c0002"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 21395, "end": 21620, "evidence": "ADA (2023) recommends a two-hour 75 OGTT at 4-12 weeks after delivery to check whether diabetes has remitted or the mother acquires T2DM, and once-a-year screening for diabetes, as 30-50% develop into T2DM in 10 years [9,37].", "text": "time horizon: 10 years", "score": 28, "kind": "atom", "claim_id": "c0003"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 8123, "end": 8361, "evidence": "The guidelines of the ADA (2023) recommend the 75 g OGTT with the following cut-off points for diagnosis: fasting glucose ≥92 mg/dL (5.1 mmol/L), a one-hour level of ≥180 mg/dL (10 mmol/L), and a two-hour level of ≥153 mg/dL (8.5 mmol/L).", "text": "fasting glucose threshold: 92 mg/dL", "score": 27, "kind": "atom", "claim_id": "c0004"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 8123, "end": 8361, "evidence": "The guidelines of the ADA (2023) recommend the 75 g OGTT with the following cut-off points for diagnosis: fasting glucose ≥92 mg/dL (5.1 mmol/L), a one-hour level of ≥180 mg/dL (10 mmol/L), and a two-hour level of ≥153 mg/dL (8.5 mmol/L).", "text": "glucose threshold: 180 mg/dL", "score": 27, "kind": "atom", "claim_id": "c0005"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 8123, "end": 8361, "evidence": "The guidelines of the ADA (2023) recommend the 75 g OGTT with the following cut-off points for diagnosis: fasting glucose ≥92 mg/dL (5.1 mmol/L), a one-hour level of ≥180 mg/dL (10 mmol/L), and a two-hour level of ≥153 mg/dL (8.5 mmol/L).", "text": "glucose threshold: 153 mg/dL", "score": 27, "kind": "atom", "claim_id": "c0006"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 8123, "end": 8361, "evidence": "The guidelines of the ADA (2023) recommend the 75 g OGTT with the following cut-off points for diagnosis: fasting glucose ≥92 mg/dL (5.1 mmol/L), a one-hour level of ≥180 mg/dL (10 mmol/L), and a two-hour level of ≥153 mg/dL (8.5 mmol/L).", "text": "OGTT glucose load: 75 g", "score": 27, "kind": "atom", "claim_id": "c0007"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 21395, "end": 21620, "evidence": "ADA (2023) recommends a two-hour 75 OGTT at 4-12 weeks after delivery to check whether diabetes has remitted or the mother acquires T2DM, and once-a-year screening for diabetes, as 30-50% develop into T2DM in 10 years [9,37].", "text": "CARE-PATHWAY: ADA (2023) recommends a two-hour 75 OGTT at 4-12 weeks after delivery to check whether diabetes has remitted or the mother acquires T2DM, an…", "score": 26, "kind": "gen_atom", "claim_id": "c0008"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 7735, "end": 7856, "evidence": "Both ADA 2023 and NICE 2022 recommend universal screening for GDM between 24-28 weeks of gestation with a 75 g OGTT [10].", "text": "GDM screening window: 24-28 weeks", "score": 23, "kind": "atom", "claim_id": "c0009"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 21395, "end": 21620, "evidence": "ADA (2023) recommends a two-hour 75 OGTT at 4-12 weeks after delivery to check whether diabetes has remitted or the mother acquires T2DM, and once-a-year screening for diabetes, as 30-50% develop into T2DM in 10 years [9,37].", "text": "ADA (2023) recommends a two-hour 75 OGTT at 4-12 weeks after delivery to check whether diabetes has remitted or the mother acquires T2DM, and once-a-year screening for diabetes, as 30-50% develop into T2DM in 10 years [9,37].", "score": 23, "kind": "sentence", "claim_id": "c0010"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 8123, "end": 8361, "evidence": "The guidelines of the ADA (2023) recommend the 75 g OGTT with the following cut-off points for diagnosis: fasting glucose ≥92 mg/dL (5.1 mmol/L), a one-hour level of ≥180 mg/dL (10 mmol/L), and a two-hour level of ≥153 mg/dL (8.5 mmol/L).", "text": "The guidelines of the ADA (2023) recommend the 75 g OGTT with the following cut-off points for diagnosis: fasting glucose ≥92 mg/dL (5.1 mmol/L), a one-hour level of ≥180 mg/dL (10 mmol/L), and a two-hour level of ≥153 mg/dL (8.5 mmol/L).", "score": 22, "kind": "sentence", "claim_id": "c0011"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 1497, "end": 1910, "evidence": "Gestational diabetes mellitus (GDM) represents approximately 90% of these cases and affects 2–5% of all pregnancies and varies in direct proportion to type 2 diabetes mellitus in the background population.[1] Pre-existing diabetes mellitus complicates 0.2% to 0.3% of pregnancies.[2] The importance of diabetes in pregnancy stems from the fact that it carries a significant risk to both the foetus and the mother.", "text": "rate range: 2-5%", "score": 21, "kind": "atom", "claim_id": "c0012"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 1497, "end": 1910, "evidence": "Gestational diabetes mellitus (GDM) represents approximately 90% of these cases and affects 2–5% of all pregnancies and varies in direct proportion to type 2 diabetes mellitus in the background population.[1] Pre-existing diabetes mellitus complicates 0.2% to 0.3% of pregnancies.[2] The importance of diabetes in pregnancy stems from the fact that it carries a significant risk to both the foetus and the mother.", "text": "rate: 90%", "score": 21, "kind": "atom", "claim_id": "c0013"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 1497, "end": 1910, "evidence": "Gestational diabetes mellitus (GDM) represents approximately 90% of these cases and affects 2–5% of all pregnancies and varies in direct proportion to type 2 diabetes mellitus in the background population.[1] Pre-existing diabetes mellitus complicates 0.2% to 0.3% of pregnancies.[2] The importance of diabetes in pregnancy stems from the fact that it carries a significant risk to both the foetus and the mother.", "text": "rate: 0.2%", "score": 21, "kind": "atom", "claim_id": "c0014"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 1497, "end": 1910, "evidence": "Gestational diabetes mellitus (GDM) represents approximately 90% of these cases and affects 2–5% of all pregnancies and varies in direct proportion to type 2 diabetes mellitus in the background population.[1] Pre-existing diabetes mellitus complicates 0.2% to 0.3% of pregnancies.[2] The importance of diabetes in pregnancy stems from the fact that it carries a significant risk to both the foetus and the mother.", "text": "rate: 0.3%", "score": 21, "kind": "atom", "claim_id": "c0015"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 10255, "end": 10433, "evidence": "The ADA and NICE-recommended targets are the preprandial blood glucose levels between 70-95 mg/dL (3.9-5.3 mmol/L) and less than 140 mg/dL (7.8 mmol/L) one hour after meals [17].", "text": "glucose threshold: 95 mg/dL", "score": 21, "kind": "atom", "claim_id": "c0016"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 10255, "end": 10433, "evidence": "The ADA and NICE-recommended targets are the preprandial blood glucose levels between 70-95 mg/dL (3.9-5.3 mmol/L) and less than 140 mg/dL (7.8 mmol/L) one hour after meals [17].", "text": "glucose threshold: 140 mg/dL", "score": 21, "kind": "atom", "claim_id": "c0017"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 19161, "end": 19535, "evidence": "These can include a balanced diet with low-glycemic index meals consisting of 40% carbohydrates, 30% protein, and 30% fats, with carbohydrate counting to help prevent hyperglycemia, as stated by ADA (2023), and NICE (2022), and regular physical activities such as brisk walking for 150 minutes per week if recommended by the gynecologist to improve insulin sensitivity [33].", "text": "rate: 40%", "score": 21, "kind": "atom", "claim_id": "c0018"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 19161, "end": 19535, "evidence": "These can include a balanced diet with low-glycemic index meals consisting of 40% carbohydrates, 30% protein, and 30% fats, with carbohydrate counting to help prevent hyperglycemia, as stated by ADA (2023), and NICE (2022), and regular physical activities such as brisk walking for 150 minutes per week if recommended by the gynecologist to improve insulin sensitivity [33].", "text": "rate: 30%", "score": 21, "kind": "atom", "claim_id": "c0019"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 7735, "end": 7856, "evidence": "Both ADA 2023 and NICE 2022 recommend universal screening for GDM between 24-28 weeks of gestation with a 75 g OGTT [10].", "text": "CARE-PATHWAY: Both ADA 2023 and NICE 2022 recommend universal screening for GDM between 24-28 weeks of gestation with a 75 g OGTT [10].", "score": 21, "kind": "gen_atom", "claim_id": "c0020"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 22133, "end": 22433, "evidence": "They should monitor their own blood glucose levels and, if the pre-prandial glucose levels are consistently above 5.5mmol/l (95 mg/dl), insulin should be commenced with the aim of keeping pre-prandial blood glucose below 5.5 mmol/l (95 mg/dl), and two hour post-prandial below 7.8 mmol/l (140 mg/dl).", "text": "glucose threshold: 95 mg/dL", "score": 20, "kind": "atom", "claim_id": "c0021"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 22133, "end": 22433, "evidence": "They should monitor their own blood glucose levels and, if the pre-prandial glucose levels are consistently above 5.5mmol/l (95 mg/dl), insulin should be commenced with the aim of keeping pre-prandial blood glucose below 5.5 mmol/l (95 mg/dl), and two hour post-prandial below 7.8 mmol/l (140 mg/dl).", "text": "glucose threshold: 140 mg/dL", "score": 20, "kind": "atom", "claim_id": "c0022"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 22522, "end": 22672, "evidence": "[20, 21, 22] A 75g oral Glucose Tolerance Test should be performed 6 weeks or more after delivery and the results interpreted by revised WHO criteria.", "text": "pregnancy timing: 6 weeks", "score": 19, "kind": "atom", "claim_id": "c0023"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 22522, "end": 22672, "evidence": "[20, 21, 22] A 75g oral Glucose Tolerance Test should be performed 6 weeks or more after delivery and the results interpreted by revised WHO criteria.", "text": "OGTT glucose load: 75 g", "score": 19, "kind": "atom", "claim_id": "c0024"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 1497, "end": 1910, "evidence": "Gestational diabetes mellitus (GDM) represents approximately 90% of these cases and affects 2–5% of all pregnancies and varies in direct proportion to type 2 diabetes mellitus in the background population.[1] Pre-existing diabetes mellitus complicates 0.2% to 0.3% of pregnancies.[2] The importance of diabetes in pregnancy stems from the fact that it carries a significant risk to both the foetus and the mother.", "text": "RISK/ASSOCIATION: Gestational diabetes mellitus (GDM) represents approximately 90% of these cases and affects 2–5% of all pregnancies and varies in direct pro…", "score": 19, "kind": "gen_atom", "claim_id": "c0025"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 10255, "end": 10433, "evidence": "The ADA and NICE-recommended targets are the preprandial blood glucose levels between 70-95 mg/dL (3.9-5.3 mmol/L) and less than 140 mg/dL (7.8 mmol/L) one hour after meals [17].", "text": "RECOMMENDATION: The ADA and NICE-recommended targets are the preprandial blood glucose levels between 70-95 mg/dL (3.9-5.3 mmol/L) and less than 140 mg/dL (…", "score": 19, "kind": "gen_atom", "claim_id": "c0026"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 19161, "end": 19535, "evidence": "These can include a balanced diet with low-glycemic index meals consisting of 40% carbohydrates, 30% protein, and 30% fats, with carbohydrate counting to help prevent hyperglycemia, as stated by ADA (2023), and NICE (2022), and regular physical activities such as brisk walking for 150 minutes per week if recommended by the gynecologist to improve insulin sensitivity [33].", "text": "RECOMMENDATION: These can include a balanced diet with low-glycemic index meals consisting of 40% carbohydrates, 30% protein, and 30% fats, with carbohydrat…", "score": 19, "kind": "gen_atom", "claim_id": "c0027"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 22133, "end": 22433, "evidence": "They should monitor their own blood glucose levels and, if the pre-prandial glucose levels are consistently above 5.5mmol/l (95 mg/dl), insulin should be commenced with the aim of keeping pre-prandial blood glucose below 5.5 mmol/l (95 mg/dl), and two hour post-prandial below 7.8 mmol/l (140 mg/dl).", "text": "RECOMMENDATION: They should monitor their own blood glucose levels and, if the pre-prandial glucose levels are consistently above 5.5mmol/l (95 mg/dl), insu…", "score": 18, "kind": "gen_atom", "claim_id": "c0028"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 20993, "end": 21286, "evidence": "Most guidelines suggest that pregnant women whose GDM is diet-controlled should be delivered at 39-40 weeks of gestation while those with poor control need to be delivered at 37-38 weeks, though the timing may vary based on individual factors, including glycemic control and fetal growth [36].", "text": "pregnancy time window: 39-40 weeks", "score": 18, "kind": "atom", "claim_id": "c0029"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 20993, "end": 21286, "evidence": "Most guidelines suggest that pregnant women whose GDM is diet-controlled should be delivered at 39-40 weeks of gestation while those with poor control need to be delivered at 37-38 weeks, though the timing may vary based on individual factors, including glycemic control and fetal growth [36].", "text": "pregnancy time window: 37-38 weeks", "score": 18, "kind": "atom", "claim_id": "c0030"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 7735, "end": 7856, "evidence": "Both ADA 2023 and NICE 2022 recommend universal screening for GDM between 24-28 weeks of gestation with a 75 g OGTT [10].", "text": "Both ADA 2023 and NICE 2022 recommend universal screening for GDM between 24-28 weeks of gestation with a 75 g OGTT [10].", "score": 18, "kind": "sentence", "claim_id": "c0031"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 22522, "end": 22672, "evidence": "[20, 21, 22] A 75g oral Glucose Tolerance Test should be performed 6 weeks or more after delivery and the results interpreted by revised WHO criteria.", "text": "RECOMMENDATION: [20, 21, 22] A 75g oral Glucose Tolerance Test should be performed 6 weeks or more after delivery and the results interpreted by revised WHO…", "score": 17, "kind": "gen_atom", "claim_id": "c0032"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 10829, "end": 11113, "evidence": "Tighter glycaemic control has an impact on maternal and foetal complications, therefore, excellent glycaemic control should be continued throughout pregnancy, fasting blood glucose should be kept < 5.5 mmol/l (<95mg/dl), post-prandial glucose < 7.8 mmol/l (<140 mg/dl) and HbA1c < 7%.", "text": "rate: 7%", "score": 16, "kind": "atom", "claim_id": "c0033"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 20014, "end": 20281, "evidence": "The prevalence may range from 1–14% of all pregnancies, depending on the population sample, with 2–5% being the most common rate.[1] GDM develops when a woman is unable to secrete sufficient insulin to compensate for the increased insulin resistance during pregnancy.", "text": "rate range: 1-14%", "score": 16, "kind": "atom", "claim_id": "c0034"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 1497, "end": 1910, "evidence": "Gestational diabetes mellitus (GDM) represents approximately 90% of these cases and affects 2–5% of all pregnancies and varies in direct proportion to type 2 diabetes mellitus in the background population.[1] Pre-existing diabetes mellitus complicates 0.2% to 0.3% of pregnancies.[2] The importance of diabetes in pregnancy stems from the fact that it carries a significant risk to both the foetus and the mother.", "text": "Gestational diabetes mellitus (GDM) represents approximately 90% of these cases and affects 2–5% of all pregnancies and varies in direct proportion to type 2 diabetes mellitus in the background population.[1] Pre-existing diabetes mellitus complicates 0.2% to 0.3% of pregnancies.[2] The importance of diabetes in pregnancy stems from the fact that it carries a significant risk to both the foetus and the mother.", "score": 16, "kind": "sentence", "claim_id": "c0035"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 1757, "end": 1889, "evidence": "A postpartum visit with 75 g oral glucose tolerance test (OGTT) at 4-12 weeks is essential for the detection of persistent diabetes.", "text": "pregnancy time window: 4-12 weeks", "score": 16, "kind": "atom", "claim_id": "c0036"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 20993, "end": 21286, "evidence": "Most guidelines suggest that pregnant women whose GDM is diet-controlled should be delivered at 39-40 weeks of gestation while those with poor control need to be delivered at 37-38 weeks, though the timing may vary based on individual factors, including glycemic control and fetal growth [36].", "text": "RECOMMENDATION: Most guidelines suggest that pregnant women whose GDM is diet-controlled should be delivered at 39-40 weeks of gestation while those with po…", "score": 16, "kind": "gen_atom", "claim_id": "c0037"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 10255, "end": 10433, "evidence": "The ADA and NICE-recommended targets are the preprandial blood glucose levels between 70-95 mg/dL (3.9-5.3 mmol/L) and less than 140 mg/dL (7.8 mmol/L) one hour after meals [17].", "text": "The ADA and NICE-recommended targets are the preprandial blood glucose levels between 70-95 mg/dL (3.9-5.3 mmol/L) and less than 140 mg/dL (7.8 mmol/L) one hour after meals [17].", "score": 16, "kind": "sentence", "claim_id": "c0038"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 19161, "end": 19535, "evidence": "These can include a balanced diet with low-glycemic index meals consisting of 40% carbohydrates, 30% protein, and 30% fats, with carbohydrate counting to help prevent hyperglycemia, as stated by ADA (2023), and NICE (2022), and regular physical activities such as brisk walking for 150 minutes per week if recommended by the gynecologist to improve insulin sensitivity [33].", "text": "These can include a balanced diet with low-glycemic index meals consisting of 40% carbohydrates, 30% protein, and 30% fats, with carbohydrate counting to help prevent hyperglycemia, as stated by ADA (2023), and NICE (2022), and regular physical activities such as brisk walking for 150 minutes per week if recommended by the gynecologist to improve insulin sensitivity [33].", "score": 16, "kind": "sentence", "claim_id": "c0039"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 22133, "end": 22433, "evidence": "They should monitor their own blood glucose levels and, if the pre-prandial glucose levels are consistently above 5.5mmol/l (95 mg/dl), insulin should be commenced with the aim of keeping pre-prandial blood glucose below 5.5 mmol/l (95 mg/dl), and two hour post-prandial below 7.8 mmol/l (140 mg/dl).", "text": "They should monitor their own blood glucose levels and, if the pre-prandial glucose levels are consistently above 5.5mmol/l (95 mg/dl), insulin should be commenced with the aim of keeping pre-prandial blood glucose below 5.5 mmol/l (95 mg/dl), and two hour post-prandial below 7.8 mmol/l (140 mg/dl).", "score": 15, "kind": "sentence", "claim_id": "c0040"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 3076, "end": 3249, "evidence": "GDM is present in 15-25% of pregnancies in the UAE, where it is driven by obesity and genetic susceptibility, while pre-existing diabetes is seen in 1-3% of pregnancies [1].", "text": "rate range: 15-25%", "score": 15, "kind": "atom", "claim_id": "c0041"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 3076, "end": 3249, "evidence": "GDM is present in 15-25% of pregnancies in the UAE, where it is driven by obesity and genetic susceptibility, while pre-existing diabetes is seen in 1-3% of pregnancies [1].", "text": "rate range: 1-3%", "score": 15, "kind": "atom", "claim_id": "c0042"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 10829, "end": 11113, "evidence": "Tighter glycaemic control has an impact on maternal and foetal complications, therefore, excellent glycaemic control should be continued throughout pregnancy, fasting blood glucose should be kept < 5.5 mmol/l (<95mg/dl), post-prandial glucose < 7.8 mmol/l (<140 mg/dl) and HbA1c < 7%.", "text": "RECOMMENDATION: Tighter glycaemic control has an impact on maternal and foetal complications, therefore, excellent glycaemic control should be continued thr…", "score": 14, "kind": "gen_atom", "claim_id": "c0043"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 20014, "end": 20281, "evidence": "The prevalence may range from 1–14% of all pregnancies, depending on the population sample, with 2–5% being the most common rate.[1] GDM develops when a woman is unable to secrete sufficient insulin to compensate for the increased insulin resistance during pregnancy.", "text": "MECHANISM: The prevalence may range from 1–14% of all pregnancies, depending on the population sample, with 2–5% being the most common rate.[1] GDM dev…", "score": 14, "kind": "gen_atom", "claim_id": "c0044"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 22522, "end": 22672, "evidence": "[20, 21, 22] A 75g oral Glucose Tolerance Test should be performed 6 weeks or more after delivery and the results interpreted by revised WHO criteria.", "text": "[20, 21, 22] A 75g oral Glucose Tolerance Test should be performed 6 weeks or more after delivery and the results interpreted by revised WHO criteria.", "score": 14, "kind": "sentence", "claim_id": "c0045"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 7857, "end": 8122, "evidence": "However, high-risk populations such as those with a BMI of 30 or more, a family history of diabetes, and a prior history of GDM or macrosomia should undergo screening earlier than 15 weeks of gestation to detect potential glucose intolerance before it worsens [11].", "text": "pregnancy timing: 15 weeks", "score": 14, "kind": "atom", "claim_id": "c0046"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 1757, "end": 1889, "evidence": "A postpartum visit with 75 g oral glucose tolerance test (OGTT) at 4-12 weeks is essential for the detection of persistent diabetes.", "text": "CARE-PATHWAY: A postpartum visit with 75 g oral glucose tolerance test (OGTT) at 4-12 weeks is essential for the detection of persistent diabetes.", "score": 14, "kind": "gen_atom", "claim_id": "c0047"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 20089, "end": 20271, "evidence": "The ADA (2023) recommends starting insulin therapy when fasting blood glucose is above 95 mg/dL (5.3 mmol/L) or when postprandial glucose levels are above 140 mg/dL (7.8 mmol/L) [8].", "text": "The ADA (2023) recommends starting insulin therapy when fasting blood glucose is above 95 mg/dL (5.3 mmol/L) or when postprandial glucose levels are above 140 mg/dL (7.8 mmol/L) [8].", "score": 14, "kind": "sentence", "claim_id": "c0048"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 20074, "end": 20261, "evidence": "The American Diabetes Association (ADA) advises that the target blood sugar levels be 95 mg/dL for fasting and 140 mg/dL or 120 mg/dL for one to two hours, respectively, following a meal.", "text": "glucose threshold: 95 mg/dL", "score": 13, "kind": "atom", "claim_id": "c0049"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 20074, "end": 20261, "evidence": "The American Diabetes Association (ADA) advises that the target blood sugar levels be 95 mg/dL for fasting and 140 mg/dL or 120 mg/dL for one to two hours, respectively, following a meal.", "text": "fasting glucose threshold: 140 mg/dL", "score": 13, "kind": "atom", "claim_id": "c0050"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 20074, "end": 20261, "evidence": "The American Diabetes Association (ADA) advises that the target blood sugar levels be 95 mg/dL for fasting and 140 mg/dL or 120 mg/dL for one to two hours, respectively, following a meal.", "text": "fasting glucose threshold: 120 mg/dL", "score": 13, "kind": "atom", "claim_id": "c0051"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 17723, "end": 17939, "evidence": "With about 20% of offspring resulting from GDM having type 2 diabetes and prediabetes by 22, it is plausible that the development of being resistant to insulin raises the chance of the child getting the disease [40].", "text": "rate: 20%", "score": 13, "kind": "atom", "claim_id": "c0052"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 15524, "end": 15667, "evidence": "One of the most common and severe short-term sequelae is macrosomia, birth weight greater than 4000-4500 grams, with a 26% incidence rate [25].", "text": "rate: 26%", "score": 13, "kind": "atom", "claim_id": "c0053"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 20993, "end": 21286, "evidence": "Most guidelines suggest that pregnant women whose GDM is diet-controlled should be delivered at 39-40 weeks of gestation while those with poor control need to be delivered at 37-38 weeks, though the timing may vary based on individual factors, including glycemic control and fetal growth [36].", "text": "Most guidelines suggest that pregnant women whose GDM is diet-controlled should be delivered at 39-40 weeks of gestation while those with poor control need to be delivered at 37-38 weeks, though the timing may vary based on individual factors, including glycemic control and fetal growth [36].", "score": 13, "kind": "sentence", "claim_id": "c0054"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 16136, "end": 16305, "evidence": "All diabetic patients should be counselled about the possibility of a neural tube defect and offered serum alphafetoprotein blood test between 15 and 19 weeks gestation.", "text": "pregnancy timing: 19 weeks", "score": 12, "kind": "atom", "claim_id": "c0055"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 18117, "end": 18257, "evidence": "If delivery is indicated before 36 weeks then administration of a steroid to the mother for 48 hours prior to delivery should be undertaken.", "text": "pregnancy timing: 36 weeks", "score": 12, "kind": "atom", "claim_id": "c0056"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 7857, "end": 8122, "evidence": "However, high-risk populations such as those with a BMI of 30 or more, a family history of diabetes, and a prior history of GDM or macrosomia should undergo screening earlier than 15 weeks of gestation to detect potential glucose intolerance before it worsens [11].", "text": "RECOMMENDATION: However, high-risk populations such as those with a BMI of 30 or more, a family history of diabetes, and a prior history of GDM or macrosomi…", "score": 12, "kind": "gen_atom", "claim_id": "c0057"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 7857, "end": 8122, "evidence": "However, high-risk populations such as those with a BMI of 30 or more, a family history of diabetes, and a prior history of GDM or macrosomia should undergo screening earlier than 15 weeks of gestation to detect potential glucose intolerance before it worsens [11].", "text": "RISK/ASSOCIATION: However, high-risk populations such as those with a BMI of 30 or more, a family history of diabetes, and a prior history of GDM or macrosomi…", "score": 12, "kind": "gen_atom", "claim_id": "c0058"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 13537, "end": 13599, "evidence": "Macrosomic babies are born in 15%-45% of GDM pregnancies [22].", "text": "rate: 15%", "score": 11, "kind": "atom", "claim_id": "c0059"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 19405, "end": 19537, "evidence": "With enough exercise, dietary changes, and lifestyle adjustments, up to 70%-85% of those with gestational diabetes are curable [42].", "text": "rate: 70%", "score": 11, "kind": "atom", "claim_id": "c0060"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 16306, "end": 16414, "evidence": "A detailed ultrasound scan at between 20 and 22 weeks for careful assessment of foetal anatomy is mandatory.", "text": "pregnancy timing: 22 weeks", "score": 11, "kind": "atom", "claim_id": "c0061"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 10829, "end": 11113, "evidence": "Tighter glycaemic control has an impact on maternal and foetal complications, therefore, excellent glycaemic control should be continued throughout pregnancy, fasting blood glucose should be kept < 5.5 mmol/l (<95mg/dl), post-prandial glucose < 7.8 mmol/l (<140 mg/dl) and HbA1c < 7%.", "text": "Tighter glycaemic control has an impact on maternal and foetal complications, therefore, excellent glycaemic control should be continued throughout pregnancy, fasting blood glucose should be kept < 5.5 mmol/l (<95mg/dl), post-prandial glucose < 7.8 mmol/l (<140 mg/dl) and HbA1c < 7%.", "score": 11, "kind": "sentence", "claim_id": "c0062"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 20014, "end": 20281, "evidence": "The prevalence may range from 1–14% of all pregnancies, depending on the population sample, with 2–5% being the most common rate.[1] GDM develops when a woman is unable to secrete sufficient insulin to compensate for the increased insulin resistance during pregnancy.", "text": "The prevalence may range from 1–14% of all pregnancies, depending on the population sample, with 2–5% being the most common rate.[1] GDM develops when a woman is unable to secrete sufficient insulin to compensate for the increased insulin resistance during pregnancy.", "score": 11, "kind": "sentence", "claim_id": "c0063"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 3251, "end": 3423, "evidence": "The prevalence of GDM significantly varies depending on population and diagnostic criteria and has been estimated to affect between 2% and 10% of pregnancies worldwide [2].", "text": "rate: 2%", "score": 11, "kind": "atom", "claim_id": "c0064"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 3251, "end": 3423, "evidence": "The prevalence of GDM significantly varies depending on population and diagnostic criteria and has been estimated to affect between 2% and 10% of pregnancies worldwide [2].", "text": "rate: 10%", "score": 11, "kind": "atom", "claim_id": "c0065"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 4151, "end": 4313, "evidence": "For those with pre-existing diabetes, maintaining glycated hemoglobin (HbA1c) <6.5% before conception can lower the risk of congenital anomalies by up to 70% [1].", "text": "rate: 6.5%", "score": 11, "kind": "atom", "claim_id": "c0066"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 4151, "end": 4313, "evidence": "For those with pre-existing diabetes, maintaining glycated hemoglobin (HbA1c) <6.5% before conception can lower the risk of congenital anomalies by up to 70% [1].", "text": "rate: 70%", "score": 11, "kind": "atom", "claim_id": "c0067"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 16294, "end": 16461, "evidence": "In the long term, in-utero exposure to high blood glucose levels is linked to a 1.5-fold higher risk of obesity in children and a 7.4-fold higher risk of T2DM [27,28].", "text": "RISK/ASSOCIATION: In the long term, in-utero exposure to high blood glucose levels is linked to a 1.5-fold higher risk of obesity in children and a 7.4-fold h…", "score": 11, "kind": "gen_atom", "claim_id": "c0068"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 1757, "end": 1889, "evidence": "A postpartum visit with 75 g oral glucose tolerance test (OGTT) at 4-12 weeks is essential for the detection of persistent diabetes.", "text": "A postpartum visit with 75 g oral glucose tolerance test (OGTT) at 4-12 weeks is essential for the detection of persistent diabetes.", "score": 11, "kind": "sentence", "claim_id": "c0069"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 16679, "end": 16751, "evidence": "Ultrasound assessment should be carried out at each visit from 26 weeks.", "text": "pregnancy timing: 26 weeks", "score": 10, "kind": "atom", "claim_id": "c0070"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 10380, "end": 10500, "evidence": "Glycaemic control should be optimised with the aim of pre-prandial blood glucose < 5.5 mmol/l (<95mg/dl) and HbA1c < 7%.", "text": "RECOMMENDATION: Glycaemic control should be optimised with the aim of pre-prandial blood glucose < 5.5 mmol/l (<95mg/dl) and HbA1c < 7%.", "score": 10, "kind": "gen_atom", "claim_id": "c0071"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 3076, "end": 3249, "evidence": "GDM is present in 15-25% of pregnancies in the UAE, where it is driven by obesity and genetic susceptibility, while pre-existing diabetes is seen in 1-3% of pregnancies [1].", "text": "GDM is present in 15-25% of pregnancies in the UAE, where it is driven by obesity and genetic susceptibility, while pre-existing diabetes is seen in 1-3% of pregnancies [1].", "score": 10, "kind": "sentence", "claim_id": "c0072"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 11922, "end": 12091, "evidence": "Preterm delivery has a prevalence of roughly 10.6% worldwide when combined with several other problematic factors such as obesity and hypertension during pregnancy [25].", "text": "rate: 10.6%", "score": 9, "kind": "atom", "claim_id": "c0073"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 7062, "end": 7185, "evidence": "Nearly 10% of women with gestational diabetes mellitus are diagnosed with diabetes mellitus shortly post giving birth [13].", "text": "rate: 10%", "score": 9, "kind": "atom", "claim_id": "c0074"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 18488, "end": 18679, "evidence": "In addition, GDM offspring are 29% more likely to suffer early-onset cardiovascular conditions such as cardiac failure, high blood pressure, deep vein thrombosis, and pulmonary embolism [41].", "text": "rate: 29%", "score": 9, "kind": "atom", "claim_id": "c0075"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 15629, "end": 15865, "evidence": "Foetal monitoring: The major risks for the foetus of a diabetic woman are congenital malformations, intra-uterine death, usually after 30 weeks and macrosomia, which may result in significant problems in labour for both mother and baby.", "text": "pregnancy timing: 30 weeks", "score": 9, "kind": "atom", "claim_id": "c0076"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 2938, "end": 3075, "evidence": "Global GDM prevalence is 2-10%, with low- and middle-income countries having a higher prevalence due to inadequate access to health care.", "text": "rate range: 2-10%", "score": 9, "kind": "atom", "claim_id": "c0077"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 11630, "end": 11697, "evidence": "CGM decreases hypoglycemia and HbA1c by 0.5% compared to SMBG [19].", "text": "rate: 0.5%", "score": 9, "kind": "atom", "claim_id": "c0078"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 12691, "end": 12900, "evidence": "It showed that women receiving insulin pumps had much better HbA1c levels, fewer severe hypoglycemic events by 35%, and fewer rates of neonatal hypoglycemia compared to women receiving insulin injections [20].", "text": "rate: 35%", "score": 9, "kind": "atom", "claim_id": "c0079"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 4151, "end": 4313, "evidence": "For those with pre-existing diabetes, maintaining glycated hemoglobin (HbA1c) <6.5% before conception can lower the risk of congenital anomalies by up to 70% [1].", "text": "RISK/ASSOCIATION: For those with pre-existing diabetes, maintaining glycated hemoglobin (HbA1c) <6.5% before conception can lower the risk of congenital anoma…", "score": 9, "kind": "gen_atom", "claim_id": "c0080"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 7857, "end": 8122, "evidence": "However, high-risk populations such as those with a BMI of 30 or more, a family history of diabetes, and a prior history of GDM or macrosomia should undergo screening earlier than 15 weeks of gestation to detect potential glucose intolerance before it worsens [11].", "text": "However, high-risk populations such as those with a BMI of 30 or more, a family history of diabetes, and a prior history of GDM or macrosomia should undergo screening earlier than 15 weeks of gestation to detect potential glucose intolerance before it worsens [11].", "score": 9, "kind": "sentence", "claim_id": "c0081"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 17219, "end": 17484, "evidence": "In 10 different countries, researchers from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study discovered a direct link between maternal hyperglycemia during pregnancy and a rise in hyperglycemia and insulin resistance in children as they grew older [38].", "text": "MECHANISM: In 10 different countries, researchers from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study discovered a direct link between ma…", "score": 8, "kind": "gen_atom", "claim_id": "c0082"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 21017, "end": 21263, "evidence": "The benefits of moderate exercise during pregnancy include a lower risk of gestational diabetes, a lower potential of larger-than-normal newborns, and a lower risk of high blood pressure problems, preterm birth, and fetal growth restriction [45].", "text": "REDUCES_RISK_OF: The benefits of moderate exercise during pregnancy include a -> gestational", "score": 8, "kind": "rel_atom", "claim_id": "c0083"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 10184, "end": 10469, "evidence": "According to a meta-analysis, pregnant women who are overweight are 2.14 times more susceptible to be diagnosed with GDM than pregnant women average in weight, obese pregnant women are 3.56 times more likely to do so, and extremely obese pregnant women are 8.56 times more likely [22].", "text": "According to a meta-analysis, pregnant women who are overweight are 2.14 times more susceptible to be diagnosed with GDM than pregnant women average in weight, obese pregnant women are 3.56 times more likely to do so, and extremely obese pregnant women are 8.56 times more likely [22].", "score": 8, "kind": "sentence", "claim_id": "c0084"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 17723, "end": 17939, "evidence": "With about 20% of offspring resulting from GDM having type 2 diabetes and prediabetes by 22, it is plausible that the development of being resistant to insulin raises the chance of the child getting the disease [40].", "text": "With about 20% of offspring resulting from GDM having type 2 diabetes and prediabetes by 22, it is plausible that the development of being resistant to insulin raises the chance of the child getting the disease [40].", "score": 8, "kind": "sentence", "claim_id": "c0085"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 12417, "end": 12624, "evidence": "Insulin therapy: Insulin regimes should be individualised but in type 1 patients multiple injection/basal bolus regime of human insulin is preferable and in type 2, twice-daily injections may be appropriate.", "text": "RECOMMENDATION: Insulin therapy: Insulin regimes should be individualised but in type 1 patients multiple injection/basal bolus regime of human insulin is p…", "score": 8, "kind": "gen_atom", "claim_id": "c0086"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 10435, "end": 10704, "evidence": "It must be noted that early pregnancy hyperglycemia is associated with an increased risk of congenital malformations, while hyperglycemia later in pregnancy results in fetal overgrowth (macrosomia) and other complications such as shoulder dystocia during delivery [18].", "text": "ASSOCIATED_WITH: It must be noted that early pregnancy hyperglycemia -> an increased", "score": 8, "kind": "rel_atom", "claim_id": "c0087"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 10435, "end": 10704, "evidence": "It must be noted that early pregnancy hyperglycemia is associated with an increased risk of congenital malformations, while hyperglycemia later in pregnancy results in fetal overgrowth (macrosomia) and other complications such as shoulder dystocia during delivery [18].", "text": "LEADS_TO: while hyperglycemia later in pregnancy -> fetal", "score": 8, "kind": "rel_atom", "claim_id": "c0088"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 17337, "end": 17505, "evidence": "Optimal glucose control during the pre-conceptual period and in the first trimester of pregnancy has been shown to significantly reduce the risk of such anomalies [30].", "text": "REDUCES_RISK_OF: first trimester of pregnancy has been shown to significantly -> such", "score": 8, "kind": "rel_atom", "claim_id": "c0089"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 17827, "end": 17931, "evidence": "Studies show that tight regulation of blood glucose in pregnancy can reduce the risk of stillbirth [31].", "text": "REDUCES_RISK_OF: show that tight regulation of blood glucose in pregnancy can -> stillbirth", "score": 8, "kind": "rel_atom", "claim_id": "c0090"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 8362, "end": 8465, "evidence": "Moreover, WHO’s diagnostic thresholds include fasting glucose ≥92 mg/dL and a two-hour ≥153 mg/dL [11].", "text": "Moreover, WHO’s diagnostic thresholds include fasting glucose ≥92 mg/dL and a two-hour ≥153 mg/dL [11].", "score": 8, "kind": "sentence", "claim_id": "c0091"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 16294, "end": 16461, "evidence": "In the long term, in-utero exposure to high blood glucose levels is linked to a 1.5-fold higher risk of obesity in children and a 7.4-fold higher risk of T2DM [27,28].", "text": "In the long term, in-utero exposure to high blood glucose levels is linked to a 1.5-fold higher risk of obesity in children and a 7.4-fold higher risk of T2DM [27,28].", "score": 8, "kind": "sentence", "claim_id": "c0092"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 15524, "end": 15667, "evidence": "One of the most common and severe short-term sequelae is macrosomia, birth weight greater than 4000-4500 grams, with a 26% incidence rate [25].", "text": "One of the most common and severe short-term sequelae is macrosomia, birth weight greater than 4000-4500 grams, with a 26% incidence rate [25].", "score": 8, "kind": "sentence", "claim_id": "c0093"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 5468, "end": 5628, "evidence": "Women having GDM are recommended to discontinue any medication they were using for the condition postpartum due to the quick return of insulin sensitivity [10].", "text": "RECOMMENDATION: Women having GDM are recommended to discontinue any medication they were using for the condition postpartum due to the quick return of insul…", "score": 7, "kind": "gen_atom", "claim_id": "c0094"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 5468, "end": 5628, "evidence": "Women having GDM are recommended to discontinue any medication they were using for the condition postpartum due to the quick return of insulin sensitivity [10].", "text": "CARE-PATHWAY: Women having GDM are recommended to discontinue any medication they were using for the condition postpartum due to the quick return of insul…", "score": 7, "kind": "gen_atom", "claim_id": "c0095"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 11204, "end": 11325, "evidence": "Macrosomic births have an about three- to fivefold increased risk of postpartum hemorrhage and genital tract injury [24].", "text": "RISK/ASSOCIATION: Macrosomic births have an about three- to fivefold increased risk of postpartum hemorrhage and genital tract injury [24].", "score": 7, "kind": "gen_atom", "claim_id": "c0096"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 11204, "end": 11325, "evidence": "Macrosomic births have an about three- to fivefold increased risk of postpartum hemorrhage and genital tract injury [24].", "text": "CARE-PATHWAY: Macrosomic births have an about three- to fivefold increased risk of postpartum hemorrhage and genital tract injury [24].", "score": 7, "kind": "gen_atom", "claim_id": "c0097"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 21264, "end": 21403, "evidence": "Additionally, pregnancy-related lifestyle modifications affect the period of postpartum, reducing the chance of postpartum depression [46].", "text": "CARE-PATHWAY: Additionally, pregnancy-related lifestyle modifications affect the period of postpartum, reducing the chance of postpartum depression [46].", "score": 7, "kind": "gen_atom", "claim_id": "c0098"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 31523, "end": 31710, "evidence": "Long-term implications involve an increased risk of developing type 2 diabetes postpartum, highlighting the importance of continued monitoring and care for women who have experienced GDM.", "text": "RISK/ASSOCIATION: Long-term implications involve an increased risk of developing type 2 diabetes postpartum, highlighting the importance of continued monitori…", "score": 7, "kind": "gen_atom", "claim_id": "c0099"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 31523, "end": 31710, "evidence": "Long-term implications involve an increased risk of developing type 2 diabetes postpartum, highlighting the importance of continued monitoring and care for women who have experienced GDM.", "text": "CARE-PATHWAY: Long-term implications involve an increased risk of developing type 2 diabetes postpartum, highlighting the importance of continued monitori…", "score": 7, "kind": "gen_atom", "claim_id": "c0100"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 8867, "end": 9014, "evidence": "These results imply that the metabolic consequences of obesity serve a key role in the degeneration of beta cells that result in diabetes mellitus.", "text": "LEADS_TO: esity serve a key role in the degeneration of beta cells tha -> diabetes", "score": 7, "kind": "rel_atom", "claim_id": "c0101"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 20430, "end": 20625, "evidence": "Women who develop GDM are at increased risk for type 2 diabetes mellitus.[14] The screening and diagnostic methods for GDM remain controversial, especially the threshold values for the diagnosis.", "text": "RISK/ASSOCIATION: Women who develop GDM are at increased risk for type 2 diabetes mellitus.[14] The screening and diagnostic methods for GDM remain controvers…", "score": 7, "kind": "gen_atom", "claim_id": "c0102"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 20430, "end": 20625, "evidence": "Women who develop GDM are at increased risk for type 2 diabetes mellitus.[14] The screening and diagnostic methods for GDM remain controversial, especially the threshold values for the diagnosis.", "text": "CARE-PATHWAY: Women who develop GDM are at increased risk for type 2 diabetes mellitus.[14] The screening and diagnostic methods for GDM remain controvers…", "score": 7, "kind": "gen_atom", "claim_id": "c0103"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 8972, "end": 9199, "evidence": "The combined oral contraceptive pill is effective if taken reliably, however, the first generation, high dose oestrogen pills should be avoided as they may increase insulin requirement and increase the risk of vascular disease.", "text": "INCREASES_RISK_OF: hould be avoided as they may increase insulin requirement an -> vascular", "score": 7, "kind": "rel_atom", "claim_id": "c0104"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 10380, "end": 10500, "evidence": "Glycaemic control should be optimised with the aim of pre-prandial blood glucose < 5.5 mmol/l (<95mg/dl) and HbA1c < 7%.", "text": "Glycaemic control should be optimised with the aim of pre-prandial blood glucose < 5.5 mmol/l (<95mg/dl) and HbA1c < 7%.", "score": 7, "kind": "sentence", "claim_id": "c0105"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 21621, "end": 21699, "evidence": "In addition, breastfeeding has been found to reduce maternal T2DM risk by 32%.", "text": "rate: 32%", "score": 7, "kind": "atom", "claim_id": "c0106"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 20574, "end": 20859, "evidence": "Fetal surveillance, including routine ultrasounds every four weeks and a fetal echocardiogram if first-trimester hyperglycemia was present, is particularly important in cases of poor glycemic control or suspected macrosomia, as these conditions increase the risk of complications [35].", "text": "RISK/ASSOCIATION: Fetal surveillance, including routine ultrasounds every four weeks and a fetal echocardiogram if first-trimester hyperglycemia was present,…", "score": 7, "kind": "gen_atom", "claim_id": "c0107"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 21875, "end": 21973, "evidence": "Lifestyle modification education for the reduction of T2DM is also a part of postpartum care [38].", "text": "CARE-PATHWAY: Lifestyle modification education for the reduction of T2DM is also a part of postpartum care [38].", "score": 7, "kind": "gen_atom", "claim_id": "c0108"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 17671, "end": 17826, "evidence": "Hyperglycemia also causes placental insufficiency, which damages the blood and oxygen supply to the fetus and generates increased risks of fetal mortality.", "text": "LEADS_TO: Hyperglycemia also -> placental", "score": 7, "kind": "rel_atom", "claim_id": "c0109"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 3896, "end": 4042, "evidence": "Maternal beta cells respond by increasing their number, insulin production, and release to sustain glucose balance despite insulin resistance [5].", "text": "MECHANISM: Maternal beta cells respond by increasing their number, insulin production, and release to sustain glucose balance despite insulin resistanc…", "score": 6, "kind": "gen_atom", "claim_id": "c0110"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 8074, "end": 8252, "evidence": "Studies on the regulation of glucose following GDM over time show declining beta cell remuneration for insulin resistance (chronic) that may also deteriorate as time passes [16].", "text": "MECHANISM: Studies on the regulation of glucose following GDM over time show declining beta cell remuneration for insulin resistance (chronic) that may…", "score": 6, "kind": "gen_atom", "claim_id": "c0111"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 8646, "end": 8866, "evidence": "Weight increase, insulin resistance, increasing C-reactive protein levels, and declining adiponectin levels are risk factors for beta cell deterioration at comparatively high rates, which leads to diabetes mellitus [18].", "text": "RISK/ASSOCIATION: Weight increase, insulin resistance, increasing C-reactive protein levels, and declining adiponectin levels are risk factors for beta cell d…", "score": 6, "kind": "gen_atom", "claim_id": "c0112"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 8646, "end": 8866, "evidence": "Weight increase, insulin resistance, increasing C-reactive protein levels, and declining adiponectin levels are risk factors for beta cell deterioration at comparatively high rates, which leads to diabetes mellitus [18].", "text": "MECHANISM: Weight increase, insulin resistance, increasing C-reactive protein levels, and declining adiponectin levels are risk factors for beta cell d…", "score": 6, "kind": "gen_atom", "claim_id": "c0113"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 9298, "end": 9506, "evidence": "Figure 2 aids in comprehending the multifaceted nature of post-GDM diabetes development and highlights the significance of managing beta cell function and addressing obesity to mitigate this risk effectively.", "text": "RISK/ASSOCIATION: Figure 2 aids in comprehending the multifaceted nature of post-GDM diabetes development and highlights the significance of managing beta cel…", "score": 6, "kind": "gen_atom", "claim_id": "c0114"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 9298, "end": 9506, "evidence": "Figure 2 aids in comprehending the multifaceted nature of post-GDM diabetes development and highlights the significance of managing beta cell function and addressing obesity to mitigate this risk effectively.", "text": "MECHANISM: Figure 2 aids in comprehending the multifaceted nature of post-GDM diabetes development and highlights the significance of managing beta cel…", "score": 6, "kind": "gen_atom", "claim_id": "c0115"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 12635, "end": 12808, "evidence": "This is corroborated by the placental expression of glucose transport proteins (GLUTs) being found to be higher in pregnancies with insulin-dependent diabetes mellitus [26].", "text": "MECHANISM: This is corroborated by the placental expression of glucose transport proteins (GLUTs) being found to be higher in pregnancies with insulin-…", "score": 6, "kind": "gen_atom", "claim_id": "c0116"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 12923, "end": 13155, "evidence": "The placenta's system A and system L amino acid transporters boost cell division and the supply of essential nutrients to the fetus as a result of elevated maternal insulin, which also causes a surge in placental mTOR activity [27].", "text": "MECHANISM: The placenta's system A and system L amino acid transporters boost cell division and the supply of essential nutrients to the fetus as a res…", "score": 6, "kind": "gen_atom", "claim_id": "c0117"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 15452, "end": 15695, "evidence": "Due to the beneficial correlation between mammary gland growth during pregnancy and circulating levels of human placental lactogen, women having gestational diabetes during their pregnancy may have a delay at the beginning of breast milk [34].", "text": "MECHANISM: Due to the beneficial correlation between mammary gland growth during pregnancy and circulating levels of human placental lactogen, women ha…", "score": 6, "kind": "gen_atom", "claim_id": "c0118"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 17485, "end": 17722, "evidence": "Additionally, compared to offspring of mothers with normal blood sugar levels, GDM progeny had a higher homeostatic model assessment of insulin resistance (HOMA-IR), waist measurement, body mass index (BMI), and triglyceride levels [39].", "text": "MECHANISM: Additionally, compared to offspring of mothers with normal blood sugar levels, GDM progeny had a higher homeostatic model assessment of insu…", "score": 6, "kind": "gen_atom", "claim_id": "c0119"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 2672, "end": 2814, "evidence": "Although one can develop GDM at any instance during the entire course of pregnancy, it is typically seen between weeks 24 and 28 of pregnancy.", "text": "Although one can develop GDM at any instance during the entire course of pregnancy, it is typically seen between weeks 24 and 28 of pregnancy.", "score": 6, "kind": "sentence", "claim_id": "c0120"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 13537, "end": 13599, "evidence": "Macrosomic babies are born in 15%-45% of GDM pregnancies [22].", "text": "Macrosomic babies are born in 15%-45% of GDM pregnancies [22].", "score": 6, "kind": "sentence", "claim_id": "c0121"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 15277, "end": 15451, "evidence": "Citrate, lactose, and total nitrogen levels take 15-24 hours longer for mothers with gestational diabetes to attain levels that are comparable to those of healthy women [33].", "text": "Citrate, lactose, and total nitrogen levels take 15-24 hours longer for mothers with gestational diabetes to attain levels that are comparable to those of healthy women [33].", "score": 6, "kind": "sentence", "claim_id": "c0122"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 19405, "end": 19537, "evidence": "With enough exercise, dietary changes, and lifestyle adjustments, up to 70%-85% of those with gestational diabetes are curable [42].", "text": "With enough exercise, dietary changes, and lifestyle adjustments, up to 70%-85% of those with gestational diabetes are curable [42].", "score": 6, "kind": "sentence", "claim_id": "c0123"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 2883, "end": 3152, "evidence": "There are two main changes which are seen during pregnancy, progressive insulin resistance that begins near mid-pregnancy and progresses through the third trimester to the level that approximates the insulin resistance seen in individuals with type 2 diabetes mellitus.", "text": "MECHANISM: There are two main changes which are seen during pregnancy, progressive insulin resistance that begins near mid-pregnancy and progresses thr…", "score": 6, "kind": "gen_atom", "claim_id": "c0124"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 703, "end": 906, "evidence": "Gestational diabetes mellitus (GDM) which manifests for the first time during pregnancy is common and on the increase, its proper management will reduce the risk of neonatal macrosomia and hypoglycaemia.", "text": "REDUCES_RISK_OF: its proper management will -> neonatal", "score": 6, "kind": "rel_atom", "claim_id": "c0125"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 11607, "end": 11715, "evidence": "Pre-prandial glucose level < 5.5 mmol/l (<95mg/dl), and postprandial level glucose <7.8 mmol/ l (<140mg/dl).", "text": "Pre-prandial glucose level < 5.5 mmol/l (<95mg/dl), and postprandial level glucose <7.8 mmol/ l (<140mg/dl).", "score": 6, "kind": "sentence", "claim_id": "c0126"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 3251, "end": 3423, "evidence": "The prevalence of GDM significantly varies depending on population and diagnostic criteria and has been estimated to affect between 2% and 10% of pregnancies worldwide [2].", "text": "The prevalence of GDM significantly varies depending on population and diagnostic criteria and has been estimated to affect between 2% and 10% of pregnancies worldwide [2].", "score": 6, "kind": "sentence", "claim_id": "c0127"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 4151, "end": 4313, "evidence": "For those with pre-existing diabetes, maintaining glycated hemoglobin (HbA1c) <6.5% before conception can lower the risk of congenital anomalies by up to 70% [1].", "text": "For those with pre-existing diabetes, maintaining glycated hemoglobin (HbA1c) <6.5% before conception can lower the risk of congenital anomalies by up to 70% [1].", "score": 6, "kind": "sentence", "claim_id": "c0128"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 5963, "end": 6373, "evidence": "As a result, most international associations such as the International Association of Diabetes and Pregnancy Study Groups (IADPSG), the American Diabetes Association (ADA), and the World Health Organization (WHO) recommend therefore to screen for overt diabetes at the first antenatal visit using an FPG, HbA1c, or 75 g oral glucose tolerance test (OGTT) with the same cut-offs as for non-pregnant populations.", "text": "As a result, most international associations such as the International Association of Diabetes and Pregnancy Study Groups (IADPSG), the American Diabetes Association (ADA), and the World Health Organization (WHO) recommend therefore to screen for overt diabetes at the first antenatal visit using an FPG, HbA1c, or 75 g oral glucose tolerance test (OGTT) with the same cut-offs as for non-pregnant populations.", "score": 6, "kind": "sentence", "claim_id": "c0129"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 996, "end": 1160, "evidence": "GDM consequences include a higher risk of maternal cardiovascular disease (CVD) and type 2 diabetes, as well as macrosomia and delivery difficulties in the newborn.", "text": "RISK/ASSOCIATION: GDM consequences include a higher risk of maternal cardiovascular disease (CVD) and type 2 diabetes, as well as macrosomia and delivery diff…", "score": 5, "kind": "gen_atom", "claim_id": "c0130"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 7549, "end": 7638, "evidence": "Similar to prenatal issues, the risk of postpartum diabetes mellitus is increased by GDM.", "text": "RISK/ASSOCIATION: Similar to prenatal issues, the risk of postpartum diabetes mellitus is increased by GDM.", "score": 5, "kind": "gen_atom", "claim_id": "c0131"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 7549, "end": 7638, "evidence": "Similar to prenatal issues, the risk of postpartum diabetes mellitus is increased by GDM.", "text": "CARE-PATHWAY: Similar to prenatal issues, the risk of postpartum diabetes mellitus is increased by GDM.", "score": 5, "kind": "gen_atom", "claim_id": "c0132"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 9962, "end": 10087, "evidence": "A greater frequency of cardiovascular risk factors and cardiovascular events is also linked to previous episodes of GDM [20].", "text": "RISK/ASSOCIATION: A greater frequency of cardiovascular risk factors and cardiovascular events is also linked to previous episodes of GDM [20].", "score": 5, "kind": "gen_atom", "claim_id": "c0133"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 11084, "end": 11203, "evidence": "Heavy bleeding and postpartum hemorrhage may occur as a result of the uterus' muscle failing to contract appropriately.", "text": "CARE-PATHWAY: Heavy bleeding and postpartum hemorrhage may occur as a result of the uterus' muscle failing to contract appropriately.", "score": 5, "kind": "gen_atom", "claim_id": "c0134"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 13600, "end": 13696, "evidence": "Additionally, GDM has been linked to a higher incidence of respiratory distress in newborns [1].", "text": "RISK/ASSOCIATION: Additionally, GDM has been linked to a higher incidence of respiratory distress in newborns [1].", "score": 5, "kind": "gen_atom", "claim_id": "c0135"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 17940, "end": 18167, "evidence": "Along with an increased risk of illnesses including cardiovascular conditions and resistance to insulin, the greater incidence of obesity in children of women with GDM is also linked to an increased risk of other diseases [40].", "text": "RISK/ASSOCIATION: Along with an increased risk of illnesses including cardiovascular conditions and resistance to insulin, the greater incidence of obesity in…", "score": 5, "kind": "gen_atom", "claim_id": "c0136"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 18315, "end": 18487, "evidence": "GDM kids are more likely to experience cardiac arrhythmias and require hospitalization for cardiovascular diseases (CVDs) as a result of increased cardiovascular risk [39].", "text": "RISK/ASSOCIATION: GDM kids are more likely to experience cardiac arrhythmias and require hospitalization for cardiovascular diseases (CVDs) as a result of inc…", "score": 5, "kind": "gen_atom", "claim_id": "c0137"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 20348, "end": 20448, "evidence": "Screening the levels of hemoglobin A1C is not as helpful for evaluating glucose control in GDM [43].", "text": "CARE-PATHWAY: Screening the levels of hemoglobin A1C is not as helpful for evaluating glucose control in GDM [43].", "score": 5, "kind": "gen_atom", "claim_id": "c0138"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 21017, "end": 21263, "evidence": "The benefits of moderate exercise during pregnancy include a lower risk of gestational diabetes, a lower potential of larger-than-normal newborns, and a lower risk of high blood pressure problems, preterm birth, and fetal growth restriction [45].", "text": "RISK/ASSOCIATION: The benefits of moderate exercise during pregnancy include a lower risk of gestational diabetes, a lower potential of larger-than-normal new…", "score": 5, "kind": "gen_atom", "claim_id": "c0139"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 17219, "end": 17484, "evidence": "In 10 different countries, researchers from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study discovered a direct link between maternal hyperglycemia during pregnancy and a rise in hyperglycemia and insulin resistance in children as they grew older [38].", "text": "In 10 different countries, researchers from the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study discovered a direct link between maternal hyperglycemia during pregnancy and a rise in hyperglycemia and insulin resistance in children as they grew older [38].", "score": 5, "kind": "sentence", "claim_id": "c0140"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 907, "end": 1075, "evidence": "Post-partum evaluation of glucose tolerance and appropriate counselling in women with GDM may help decrease the high risk of subsequent type 2 diabetes in the longterm.", "text": "RISK/ASSOCIATION: Post-partum evaluation of glucose tolerance and appropriate counselling in women with GDM may help decrease the high risk of subsequent type…", "score": 5, "kind": "gen_atom", "claim_id": "c0141"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 19807, "end": 20012, "evidence": "Nevertheless, ethnicity has been proven to be an independent risk factor for GDM, which varies in prevalence in direct proportion to the prevalence of Type 2 diabetes in a given population or ethnic group.", "text": "RISK/ASSOCIATION: Nevertheless, ethnicity has been proven to be an independent risk factor for GDM, which varies in prevalence in direct proportion to the pre…", "score": 5, "kind": "gen_atom", "claim_id": "c0142"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 12417, "end": 12624, "evidence": "Insulin therapy: Insulin regimes should be individualised but in type 1 patients multiple injection/basal bolus regime of human insulin is preferable and in type 2, twice-daily injections may be appropriate.", "text": "Insulin therapy: Insulin regimes should be individualised but in type 1 patients multiple injection/basal bolus regime of human insulin is preferable and in type 2, twice-daily injections may be appropriate.", "score": 5, "kind": "sentence", "claim_id": "c0143"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 1104, "end": 1257, "evidence": "A comparative analysis of guidelines from the ADA, NICE, and WHO was performed to evaluate prevalence, therapeutic approaches, and postpartum management.", "text": "CARE-PATHWAY: A comparative analysis of guidelines from the ADA, NICE, and WHO was performed to evaluate prevalence, therapeutic approaches, and postpartu…", "score": 5, "kind": "gen_atom", "claim_id": "c0144"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 4314, "end": 4529, "evidence": "Also, the goal is to convert from teratogenic medication, such as angiotensin-converting enzyme (ACE) inhibitors, to insulin safely, attain the best possible control, and minimize risk while changing medication [3].", "text": "RISK/ASSOCIATION: Also, the goal is to convert from teratogenic medication, such as angiotensin-converting enzyme (ACE) inhibitors, to insulin safely, attain…", "score": 5, "kind": "gen_atom", "claim_id": "c0145"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 4530, "end": 4749, "evidence": "It has been seen that women with a family history of diabetes, a history of GDM, or a history of having given birth to a macrosomic baby are at higher risk of developing GDM, and thus early intervention is critical [4].", "text": "RISK/ASSOCIATION: It has been seen that women with a family history of diabetes, a history of GDM, or a history of having given birth to a macrosomic baby are…", "score": 5, "kind": "gen_atom", "claim_id": "c0146"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 6545, "end": 6687, "evidence": "While HbA1c is useful for screening diabetes, its lower sensitivity in pregnancy, due to erythrocyte turnover, limits its utility for GDM [8].", "text": "CARE-PATHWAY: While HbA1c is useful for screening diabetes, its lower sensitivity in pregnancy, due to erythrocyte turnover, limits its utility for GDM [8…", "score": 5, "kind": "gen_atom", "claim_id": "c0147"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 10435, "end": 10704, "evidence": "It must be noted that early pregnancy hyperglycemia is associated with an increased risk of congenital malformations, while hyperglycemia later in pregnancy results in fetal overgrowth (macrosomia) and other complications such as shoulder dystocia during delivery [18].", "text": "RISK/ASSOCIATION: It must be noted that early pregnancy hyperglycemia is associated with an increased risk of congenital malformations, while hyperglycemia la…", "score": 5, "kind": "gen_atom", "claim_id": "c0148"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 13105, "end": 13379, "evidence": "Insulin pumps, although beneficial, require careful monitoring and pose some drawbacks, including a risk of infection due to inadequate site rotation and limited access or coverage, particularly in low-resource settings where cost is likely to be a significant barrier [21].", "text": "RISK/ASSOCIATION: Insulin pumps, although beneficial, require careful monitoring and pose some drawbacks, including a risk of infection due to inadequate site…", "score": 5, "kind": "gen_atom", "claim_id": "c0149"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 17337, "end": 17505, "evidence": "Optimal glucose control during the pre-conceptual period and in the first trimester of pregnancy has been shown to significantly reduce the risk of such anomalies [30].", "text": "RISK/ASSOCIATION: Optimal glucose control during the pre-conceptual period and in the first trimester of pregnancy has been shown to significantly reduce the…", "score": 5, "kind": "gen_atom", "claim_id": "c0150"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 17827, "end": 17931, "evidence": "Studies show that tight regulation of blood glucose in pregnancy can reduce the risk of stillbirth [31].", "text": "RISK/ASSOCIATION: Studies show that tight regulation of blood glucose in pregnancy can reduce the risk of stillbirth [31].", "score": 5, "kind": "gen_atom", "claim_id": "c0151"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 21700, "end": 21874, "evidence": "Postpartum care also involves follow-up in the scenario of women with pre-gestational diabetes in order to treat their diabetes and prevent its complications in the long run.", "text": "CARE-PATHWAY: Postpartum care also involves follow-up in the scenario of women with pre-gestational diabetes in order to treat their diabetes and prevent…", "score": 5, "kind": "gen_atom", "claim_id": "c0152"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 22148, "end": 22284, "evidence": "Early diagnosis, tight glycemic control, and follow-up during pregnancy and into the postpartum period are underlined in the guidelines.", "text": "CARE-PATHWAY: Early diagnosis, tight glycemic control, and follow-up during pregnancy and into the postpartum period are underlined in the guidelines.", "score": 5, "kind": "gen_atom", "claim_id": "c0153"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 687, "end": 847, "evidence": "In most cases, hyperglycemia is caused by impaired glucose tolerance caused by pancreatic beta cell dysfunction in the background of chronic insulin resistance.", "text": "MECHANISM: In most cases, hyperglycemia is caused by impaired glucose tolerance caused by pancreatic beta cell dysfunction in the background of chronic…", "score": 4, "kind": "gen_atom", "claim_id": "c0154"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 1390, "end": 1666, "evidence": "Unfortunately, there is no widely acknowledged treatment or preventative strategy for GDM at the moment, except lifestyle modification (diet and exercise) and, on occasion, insulin therapy, which is only of limited value due to the insulin resistance that is commonly present.", "text": "MECHANISM: Unfortunately, there is no widely acknowledged treatment or preventative strategy for GDM at the moment, except lifestyle modification (diet…", "score": 4, "kind": "gen_atom", "claim_id": "c0155"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 3457, "end": 3587, "evidence": "However, if regular levels of insulin fail to achieve the desired response from insulin receptors, insulin resistance can develop.", "text": "MECHANISM: However, if regular levels of insulin fail to achieve the desired response from insulin receptors, insulin resistance can develop.", "score": 4, "kind": "gen_atom", "claim_id": "c0156"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 3704, "end": 3895, "evidence": "This insulin resistance is a natural part of a healthy pregnancy and is induced by placental hormones to ensure the fetus receives the necessary nourishment for proper growth and development.", "text": "MECHANISM: This insulin resistance is a natural part of a healthy pregnancy and is induced by placental hormones to ensure the fetus receives the neces…", "score": 4, "kind": "gen_atom", "claim_id": "c0157"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 4043, "end": 4203, "evidence": "However, when maternal beta cells cannot adapt to the metabolic changes associated with pregnancy, gestational diabetes mellitus (GDM) results in hyperglycemia.", "text": "RISK/ASSOCIATION: However, when maternal beta cells cannot adapt to the metabolic changes associated with pregnancy, gestational diabetes mellitus (GDM) resul…", "score": 4, "kind": "gen_atom", "claim_id": "c0158"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 8253, "end": 8481, "evidence": "Markers of rather severe decompensation, such as elevated glucose levels, noticeable insulin resistance, and impaired beta cell activity, are risk factors for the relatively quick onset of diabetes mellitus following childbirth.", "text": "RISK/ASSOCIATION: Markers of rather severe decompensation, such as elevated glucose levels, noticeable insulin resistance, and impaired beta cell activity, ar…", "score": 4, "kind": "gen_atom", "claim_id": "c0159"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 8253, "end": 8481, "evidence": "Markers of rather severe decompensation, such as elevated glucose levels, noticeable insulin resistance, and impaired beta cell activity, are risk factors for the relatively quick onset of diabetes mellitus following childbirth.", "text": "MECHANISM: Markers of rather severe decompensation, such as elevated glucose levels, noticeable insulin resistance, and impaired beta cell activity, ar…", "score": 4, "kind": "gen_atom", "claim_id": "c0160"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 9518, "end": 9612, "evidence": "Metabolic factors influencing post-GDM: the role of beta cell function and obesity management.", "text": "MECHANISM: Metabolic factors influencing post-GDM: the role of beta cell function and obesity management.", "score": 4, "kind": "gen_atom", "claim_id": "c0161"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 5468, "end": 5628, "evidence": "Women having GDM are recommended to discontinue any medication they were using for the condition postpartum due to the quick return of insulin sensitivity [10].", "text": "Women having GDM are recommended to discontinue any medication they were using for the condition postpartum due to the quick return of insulin sensitivity [10].", "score": 4, "kind": "sentence", "claim_id": "c0162"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 11204, "end": 11325, "evidence": "Macrosomic births have an about three- to fivefold increased risk of postpartum hemorrhage and genital tract injury [24].", "text": "Macrosomic births have an about three- to fivefold increased risk of postpartum hemorrhage and genital tract injury [24].", "score": 4, "kind": "sentence", "claim_id": "c0163"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 21264, "end": 21403, "evidence": "Additionally, pregnancy-related lifestyle modifications affect the period of postpartum, reducing the chance of postpartum depression [46].", "text": "Additionally, pregnancy-related lifestyle modifications affect the period of postpartum, reducing the chance of postpartum depression [46].", "score": 4, "kind": "sentence", "claim_id": "c0164"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 31523, "end": 31710, "evidence": "Long-term implications involve an increased risk of developing type 2 diabetes postpartum, highlighting the importance of continued monitoring and care for women who have experienced GDM.", "text": "Long-term implications involve an increased risk of developing type 2 diabetes postpartum, highlighting the importance of continued monitoring and care for women who have experienced GDM.", "score": 4, "kind": "sentence", "claim_id": "c0165"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 7062, "end": 7185, "evidence": "Nearly 10% of women with gestational diabetes mellitus are diagnosed with diabetes mellitus shortly post giving birth [13].", "text": "Nearly 10% of women with gestational diabetes mellitus are diagnosed with diabetes mellitus shortly post giving birth [13].", "score": 4, "kind": "sentence", "claim_id": "c0166"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 18488, "end": 18679, "evidence": "In addition, GDM offspring are 29% more likely to suffer early-onset cardiovascular conditions such as cardiac failure, high blood pressure, deep vein thrombosis, and pulmonary embolism [41].", "text": "In addition, GDM offspring are 29% more likely to suffer early-onset cardiovascular conditions such as cardiac failure, high blood pressure, deep vein thrombosis, and pulmonary embolism [41].", "score": 4, "kind": "sentence", "claim_id": "c0167"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 15629, "end": 15865, "evidence": "Foetal monitoring: The major risks for the foetus of a diabetic woman are congenital malformations, intra-uterine death, usually after 30 weeks and macrosomia, which may result in significant problems in labour for both mother and baby.", "text": "Foetal monitoring: The major risks for the foetus of a diabetic woman are congenital malformations, intra-uterine death, usually after 30 weeks and macrosomia, which may result in significant problems in labour for both mother and baby.", "score": 4, "kind": "sentence", "claim_id": "c0168"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 20430, "end": 20625, "evidence": "Women who develop GDM are at increased risk for type 2 diabetes mellitus.[14] The screening and diagnostic methods for GDM remain controversial, especially the threshold values for the diagnosis.", "text": "Women who develop GDM are at increased risk for type 2 diabetes mellitus.[14] The screening and diagnostic methods for GDM remain controversial, especially the threshold values for the diagnosis.", "score": 4, "kind": "sentence", "claim_id": "c0169"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 3881, "end": 4132, "evidence": "Risks to the Foetus & the Neonate (Tables 1 & 2): if the mother has hyperglycaemia, the foetus will be exposed to either sustained hyperglycaemia or intermittent pulses of hyperglycaemia; both situations prematurely stimulate foetal insulin secretion.", "text": "Risks to the Foetus & the Neonate (Tables 1 & 2): if the mother has hyperglycaemia, the foetus will be exposed to either sustained hyperglycaemia or intermittent pulses of hyperglycaemia; both situations prematurely stimulate foetal insulin secretion.", "score": 4, "kind": "sentence", "claim_id": "c0170"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 2938, "end": 3075, "evidence": "Global GDM prevalence is 2-10%, with low- and middle-income countries having a higher prevalence due to inadequate access to health care.", "text": "Global GDM prevalence is 2-10%, with low- and middle-income countries having a higher prevalence due to inadequate access to health care.", "score": 4, "kind": "sentence", "claim_id": "c0171"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 11630, "end": 11697, "evidence": "CGM decreases hypoglycemia and HbA1c by 0.5% compared to SMBG [19].", "text": "CGM decreases hypoglycemia and HbA1c by 0.5% compared to SMBG [19].", "score": 4, "kind": "sentence", "claim_id": "c0172"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 12691, "end": 12900, "evidence": "It showed that women receiving insulin pumps had much better HbA1c levels, fewer severe hypoglycemic events by 35%, and fewer rates of neonatal hypoglycemia compared to women receiving insulin injections [20].", "text": "It showed that women receiving insulin pumps had much better HbA1c levels, fewer severe hypoglycemic events by 35%, and fewer rates of neonatal hypoglycemia compared to women receiving insulin injections [20].", "score": 4, "kind": "sentence", "claim_id": "c0173"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 20574, "end": 20859, "evidence": "Fetal surveillance, including routine ultrasounds every four weeks and a fetal echocardiogram if first-trimester hyperglycemia was present, is particularly important in cases of poor glycemic control or suspected macrosomia, as these conditions increase the risk of complications [35].", "text": "Fetal surveillance, including routine ultrasounds every four weeks and a fetal echocardiogram if first-trimester hyperglycemia was present, is particularly important in cases of poor glycemic control or suspected macrosomia, as these conditions increase the risk of complications [35].", "score": 4, "kind": "sentence", "claim_id": "c0174"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 21875, "end": 21973, "evidence": "Lifestyle modification education for the reduction of T2DM is also a part of postpartum care [38].", "text": "Lifestyle modification education for the reduction of T2DM is also a part of postpartum care [38].", "score": 4, "kind": "sentence", "claim_id": "c0175"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 2685, "end": 2937, "evidence": "Diabetes can be classified broadly into two categories: pre-gestational diabetes, which involves type 1 and type 2 diabetes diagnosed before pregnancy, and gestational diabetes mellitus (GDM), which emerges during pregnancy and corrects after delivery.", "text": "Diabetes can be classified broadly into two categories: pre-gestational diabetes, which involves type 1 and type 2 diabetes diagnosed before pregnancy, and gestational diabetes mellitus (GDM), which emerges during pregnancy and corrects after delivery.", "score": 4, "kind": "sentence", "claim_id": "c0176"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 3633, "end": 3821, "evidence": "In contrast, fetal risks include macrosomia, birth defects, preterm birth, neonatal hypoglycemia, and long-term risks such as obesity and type 2 diabetes mellitus (T2DM) later in life [3].", "text": "In contrast, fetal risks include macrosomia, birth defects, preterm birth, neonatal hypoglycemia, and long-term risks such as obesity and type 2 diabetes mellitus (T2DM) later in life [3].", "score": 4, "kind": "sentence", "claim_id": "c0177"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 9340, "end": 9440, "evidence": "Moreover, children born to women with GDM can inherit type 1 diabetes despite glycemic control [14].", "text": "Moreover, children born to women with GDM can inherit type 1 diabetes despite glycemic control [14].", "score": 4, "kind": "sentence", "claim_id": "c0178"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 3082, "end": 3224, "evidence": "During pregnancy, the body becomes less responsive to insulin, which leads to an increased production of insulin by pancreatic beta cells [4].", "text": "During pregnancy, the body becomes less responsive to insulin, which leads to an increased production of insulin by pancreatic beta cells [4].", "score": 3, "kind": "sentence", "claim_id": "c0179"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 3588, "end": 3703, "evidence": "Consequently, beta cells must produce more insulin than usual to maintain normal maternal blood glucose levels [1].", "text": "Consequently, beta cells must produce more insulin than usual to maintain normal maternal blood glucose levels [1].", "score": 3, "kind": "sentence", "claim_id": "c0180"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 3896, "end": 4042, "evidence": "Maternal beta cells respond by increasing their number, insulin production, and release to sustain glucose balance despite insulin resistance [5].", "text": "Maternal beta cells respond by increasing their number, insulin production, and release to sustain glucose balance despite insulin resistance [5].", "score": 3, "kind": "sentence", "claim_id": "c0181"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 8074, "end": 8252, "evidence": "Studies on the regulation of glucose following GDM over time show declining beta cell remuneration for insulin resistance (chronic) that may also deteriorate as time passes [16].", "text": "Studies on the regulation of glucose following GDM over time show declining beta cell remuneration for insulin resistance (chronic) that may also deteriorate as time passes [16].", "score": 3, "kind": "sentence", "claim_id": "c0182"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 8646, "end": 8866, "evidence": "Weight increase, insulin resistance, increasing C-reactive protein levels, and declining adiponectin levels are risk factors for beta cell deterioration at comparatively high rates, which leads to diabetes mellitus [18].", "text": "Weight increase, insulin resistance, increasing C-reactive protein levels, and declining adiponectin levels are risk factors for beta cell deterioration at comparatively high rates, which leads to diabetes mellitus [18].", "score": 3, "kind": "sentence", "claim_id": "c0183"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 9298, "end": 9506, "evidence": "Figure 2 aids in comprehending the multifaceted nature of post-GDM diabetes development and highlights the significance of managing beta cell function and addressing obesity to mitigate this risk effectively.", "text": "Figure 2 aids in comprehending the multifaceted nature of post-GDM diabetes development and highlights the significance of managing beta cell function and addressing obesity to mitigate this risk effectively.", "score": 3, "kind": "sentence", "claim_id": "c0184"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 12635, "end": 12808, "evidence": "This is corroborated by the placental expression of glucose transport proteins (GLUTs) being found to be higher in pregnancies with insulin-dependent diabetes mellitus [26].", "text": "This is corroborated by the placental expression of glucose transport proteins (GLUTs) being found to be higher in pregnancies with insulin-dependent diabetes mellitus [26].", "score": 3, "kind": "sentence", "claim_id": "c0185"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 12923, "end": 13155, "evidence": "The placenta's system A and system L amino acid transporters boost cell division and the supply of essential nutrients to the fetus as a result of elevated maternal insulin, which also causes a surge in placental mTOR activity [27].", "text": "The placenta's system A and system L amino acid transporters boost cell division and the supply of essential nutrients to the fetus as a result of elevated maternal insulin, which also causes a surge in placental mTOR activity [27].", "score": 3, "kind": "sentence", "claim_id": "c0186"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 15452, "end": 15695, "evidence": "Due to the beneficial correlation between mammary gland growth during pregnancy and circulating levels of human placental lactogen, women having gestational diabetes during their pregnancy may have a delay at the beginning of breast milk [34].", "text": "Due to the beneficial correlation between mammary gland growth during pregnancy and circulating levels of human placental lactogen, women having gestational diabetes during their pregnancy may have a delay at the beginning of breast milk [34].", "score": 3, "kind": "sentence", "claim_id": "c0187"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 17485, "end": 17722, "evidence": "Additionally, compared to offspring of mothers with normal blood sugar levels, GDM progeny had a higher homeostatic model assessment of insulin resistance (HOMA-IR), waist measurement, body mass index (BMI), and triglyceride levels [39].", "text": "Additionally, compared to offspring of mothers with normal blood sugar levels, GDM progeny had a higher homeostatic model assessment of insulin resistance (HOMA-IR), waist measurement, body mass index (BMI), and triglyceride levels [39].", "score": 3, "kind": "sentence", "claim_id": "c0188"}
{"doc": "Diabetes_mellitus_and_pregnancy.txt", "start": 2883, "end": 3152, "evidence": "There are two main changes which are seen during pregnancy, progressive insulin resistance that begins near mid-pregnancy and progresses through the third trimester to the level that approximates the insulin resistance seen in individuals with type 2 diabetes mellitus.", "text": "There are two main changes which are seen during pregnancy, progressive insulin resistance that begins near mid-pregnancy and progresses through the third trimester to the level that approximates the insulin resistance seen in individuals with type 2 diabetes mellitus.", "score": 3, "kind": "sentence", "claim_id": "c0189"}
{"doc": "Management_of_Diabetes_in_Pregnancy_A_Review_of_Clinical_Guidelines_Practices.txt", "start": 7694, "end": 7734, "evidence": "The most widely used method is the OGTT.", "text": "The most widely used method is the OGTT.", "score": 3, "kind": "sentence", "claim_id": "c0190"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 996, "end": 1160, "evidence": "GDM consequences include a higher risk of maternal cardiovascular disease (CVD) and type 2 diabetes, as well as macrosomia and delivery difficulties in the newborn.", "text": "GDM consequences include a higher risk of maternal cardiovascular disease (CVD) and type 2 diabetes, as well as macrosomia and delivery difficulties in the newborn.", "score": 2, "kind": "sentence", "claim_id": "c0191"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 2815, "end": 2948, "evidence": "Additionally, the prevalence of GDM is growing globally due to an increase in maternal weight gain, maternal age, and inactivity [3].", "text": "Additionally, the prevalence of GDM is growing globally due to an increase in maternal weight gain, maternal age, and inactivity [3].", "score": 2, "kind": "sentence", "claim_id": "c0192"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 7549, "end": 7638, "evidence": "Similar to prenatal issues, the risk of postpartum diabetes mellitus is increased by GDM.", "text": "Similar to prenatal issues, the risk of postpartum diabetes mellitus is increased by GDM.", "score": 2, "kind": "sentence", "claim_id": "c0193"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 8482, "end": 8645, "evidence": "Women exhibiting these traits might surpass the threshold of glucose levels defining diabetes mellitus following a slight decline in their physical condition [17].", "text": "Women exhibiting these traits might surpass the threshold of glucose levels defining diabetes mellitus following a slight decline in their physical condition [17].", "score": 2, "kind": "sentence", "claim_id": "c0194"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 9962, "end": 10087, "evidence": "A greater frequency of cardiovascular risk factors and cardiovascular events is also linked to previous episodes of GDM [20].", "text": "A greater frequency of cardiovascular risk factors and cardiovascular events is also linked to previous episodes of GDM [20].", "score": 2, "kind": "sentence", "claim_id": "c0195"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 11084, "end": 11203, "evidence": "Heavy bleeding and postpartum hemorrhage may occur as a result of the uterus' muscle failing to contract appropriately.", "text": "Heavy bleeding and postpartum hemorrhage may occur as a result of the uterus' muscle failing to contract appropriately.", "score": 2, "kind": "sentence", "claim_id": "c0196"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 13600, "end": 13696, "evidence": "Additionally, GDM has been linked to a higher incidence of respiratory distress in newborns [1].", "text": "Additionally, GDM has been linked to a higher incidence of respiratory distress in newborns [1].", "score": 2, "kind": "sentence", "claim_id": "c0197"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 17940, "end": 18167, "evidence": "Along with an increased risk of illnesses including cardiovascular conditions and resistance to insulin, the greater incidence of obesity in children of women with GDM is also linked to an increased risk of other diseases [40].", "text": "Along with an increased risk of illnesses including cardiovascular conditions and resistance to insulin, the greater incidence of obesity in children of women with GDM is also linked to an increased risk of other diseases [40].", "score": 2, "kind": "sentence", "claim_id": "c0198"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 18315, "end": 18487, "evidence": "GDM kids are more likely to experience cardiac arrhythmias and require hospitalization for cardiovascular diseases (CVDs) as a result of increased cardiovascular risk [39].", "text": "GDM kids are more likely to experience cardiac arrhythmias and require hospitalization for cardiovascular diseases (CVDs) as a result of increased cardiovascular risk [39].", "score": 2, "kind": "sentence", "claim_id": "c0199"}
{"doc": "A Comprehensive_Review_of_Gestational_Diabetes_Mellitus.txt", "start": 20348, "end": 20448, "evidence": "Screening the levels of hemoglobin A1C is not as helpful for evaluating glucose control in GDM [43].", "text": "Screening the levels of hemoglobin A1C is not as helpful for evaluating glucose control in GDM [43].", "score": 2, "kind": "sentence", "claim_id": "c0200"}
